These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 12753499)
1. The cholera toxin B subunit is a mucosal adjuvant for oral tolerance induction in type 1 diabetes. Bregenholt S; Wang M; Wolfe T; Hughes A; Baerentzen L; Dyrberg T; von Herrath MG; Petersen JS Scand J Immunol; 2003 May; 57(5):432-8. PubMed ID: 12753499 [TBL] [Abstract][Full Text] [Related]
2. Protection against autoimmune diabetes by silkworm-produced GFP-tagged CTB-insulin fusion protein. Meng Q; Wang W; Shi X; Jin Y; Zhang Y Clin Dev Immunol; 2011; 2011():831704. PubMed ID: 21765853 [TBL] [Abstract][Full Text] [Related]
3. Neither B lymphocytes nor antibodies directed against self antigens of the islets of Langerhans are required for development of virus-induced autoimmune diabetes. Holz A; Dyrberg T; Hagopian W; Homann D; von Herrath M; Oldstone MB J Immunol; 2000 Nov; 165(10):5945-53. PubMed ID: 11067957 [TBL] [Abstract][Full Text] [Related]
5. Genetic fusion of human insulin B-chain to the B-subunit of cholera toxin enhances in vitro antigen presentation and induction of bystander suppression in vivo. Sadeghi H; Bregenholt S; Wegmann D; Petersen JS; Holmgren J; Lebens M Immunology; 2002 Jun; 106(2):237-45. PubMed ID: 12047753 [TBL] [Abstract][Full Text] [Related]
6. Cholera toxin subunit B peptide fusion proteins reveal impaired oral tolerance induction in diabetes-prone but not in diabetes-resistant mice. Presa M; Ortiz AZ; Garabatos N; Izquierdo C; Rivas EI; Teyton L; Mora C; Serreze D; Stratmann T Eur J Immunol; 2013 Nov; 43(11):2969-79. PubMed ID: 23925934 [TBL] [Abstract][Full Text] [Related]
7. Coupling of oral human or porcine insulin to the B subunit of cholera toxin (CTB) overcomes critical antigenic differences for prevention of type I diabetes. Petersen JS; Bregenholt S; Apostolopolous V; Homann D; Wolfe T; Hughes A; De Jongh K; Wang M; Dyrberg T; Von Herrath MG Clin Exp Immunol; 2003 Oct; 134(1):38-45. PubMed ID: 12974752 [TBL] [Abstract][Full Text] [Related]
8. Nasal administration of CTB-insulin induces active tolerance against autoimmune diabetes in non-obese diabetic (NOD) mice. Aspord C; Thivolet C Clin Exp Immunol; 2002 Nov; 130(2):204-11. PubMed ID: 12390307 [TBL] [Abstract][Full Text] [Related]
9. Production of a recombinant cholera toxin B subunit-insulin B chain peptide hybrid protein by Brevibacillus choshinensis expression system as a nasal vaccine against autoimmune diabetes. Yuki Y; Hara-Yakoyama C; Guadiz AA; Udaka S; Kiyono H; Chatterjee S Biotechnol Bioeng; 2005 Dec; 92(7):803-9. PubMed ID: 16142801 [TBL] [Abstract][Full Text] [Related]
10. Suppression of diabetes in non-obese diabetic (NOD) mice by oral administration of a cholera toxin B subunit-insulin B chain fusion protein vaccine produced in silkworm. Gong Z; Jin Y; Zhang Y Vaccine; 2007 Feb; 25(8):1444-51. PubMed ID: 17113687 [TBL] [Abstract][Full Text] [Related]
11. Oral Administration of Silkworm-Produced GAD65 and Insulin Bi-Autoantigens against Type 1 Diabetes. Liu B; Yue Y; Yang Y; Jin Y PLoS One; 2016; 11(1):e0147260. PubMed ID: 26783749 [TBL] [Abstract][Full Text] [Related]
12. Insulin in oral immune "tolerance": a one-amino acid change in the B chain makes the difference. Homann D; Dyrberg T; Petersen J; Oldstone MB; von Herrath MG J Immunol; 1999 Aug; 163(4):1833-8. PubMed ID: 10438916 [TBL] [Abstract][Full Text] [Related]
13. Expression of cholera toxin B subunit and assembly as functional oligomers in silkworm. Gong ZH; Jin HQ; Jin YF; Zhang YZ J Biochem Mol Biol; 2005 Nov; 38(6):717-24. PubMed ID: 16336788 [TBL] [Abstract][Full Text] [Related]
14. Altered B:9-23 insulin, when administered intranasally with cholera toxin adjuvant, suppresses the expression of insulin autoantibodies and prevents diabetes. Kobayashi M; Abiru N; Arakawa T; Fukushima K; Zhou H; Kawasaki E; Yamasaki H; Liu E; Miao D; Wong FS; Eisenbarth GS; Eguchi K J Immunol; 2007 Aug; 179(4):2082-8. PubMed ID: 17675466 [TBL] [Abstract][Full Text] [Related]
15. Suppression of hyperglycemia in NOD mice after inoculation with recombinant vaccinia viruses. Dénes B; Yu J; Fodor N; Takátsy Z; Fodor I; Langridge WH Mol Biotechnol; 2006 Nov; 34(3):317-27. PubMed ID: 17284779 [TBL] [Abstract][Full Text] [Related]
16. Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM. von Herrath M; Holz A J Autoimmun; 1997 Jun; 10(3):231-8. PubMed ID: 9218748 [TBL] [Abstract][Full Text] [Related]
17. Glutamic acid decarboxylase epitope protects against autoimmune diabetes through activation of Th2 immune response and induction of possible regulatory mechanism. Gong Z; Pan L; Le Y; Liu Q; Zhou M; Xing W; Zhuo R; Wang S; Guo J Vaccine; 2010 May; 28(24):4052-8. PubMed ID: 20406664 [TBL] [Abstract][Full Text] [Related]
18. B lymphocytes promote expansion of regulatory T cells in oral tolerance: powerful induction by antigen coupled to cholera toxin B subunit. Sun JB; Flach CF; Czerkinsky C; Holmgren J J Immunol; 2008 Dec; 181(12):8278-87. PubMed ID: 19050244 [TBL] [Abstract][Full Text] [Related]
19. Oral tolerance induction by mucosal administration of cholera toxin B-coupled antigen involves T-cell proliferation in vivo and is not affected by depletion of CD25+ T cells. George Chandy A; Hultkrantz S; Raghavan S; Czerkinsky C; Lebens M; Telemo E; Holmgren J Immunology; 2006 Jul; 118(3):311-20. PubMed ID: 16827892 [TBL] [Abstract][Full Text] [Related]
20. Oral administration of a cholera toxin B subunit-insulin fusion protein produced in silkworm protects against autoimmune diabetes. Gong Z; Jin Y; Zhang Y J Biotechnol; 2005 Sep; 119(1):93-105. PubMed ID: 16024127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]